---
title: Inhalation & Nasal Dosage Manufacturing CDMOs in Europe
path: /services/inhalation-dosage-manufacturing/europe
companies_count: 9
---

# Inhalation & Nasal Dosage Manufacturing CDMOs in Europe

9 published CDMOs match Inhalation & Nasal Dosage Manufacturing in Europe.

Locations in this set include United States, France, China, United Kingdom, Switzerland, and Brazil.

Capabilities that show up most often in this set: Small Molecule, Biologics (Other), Gene Therapy, AAV / Viral Vector Platform, and Biologics (Monoclonal Antibodies).

## Matching companies

- [Catalent](/companies/catalent)
  - Global CDMO providing end-to-end contract development and manufacturing for pharma, biotech, and consumer health. Delivers 60+ billion doses annually across small molecules, biologics, cell & gene therapies, and clinical supply.
- [Delpharm](/companies/delpharm)
  - Top-5 global CDMO with 18 production sites across Europe and North America, specializing in solid, semi-solid, non-sterile and sterile liquid dosage forms including prefilled syringes, nasal sprays, and injectables; capacity to produce over 300 million units annually.
- [Ethypharm](/companies/ethypharm)
  - Ethypharm is a leading mid-size international specialty pharmaceutical company with strong European roots.
- [Hovione](/companies/hovione)
  - Specialist integrated CDMO with over 60 years of experience in contract development and manufacturing for pharmaceutical customers, supporting both new and off-patent drug programs.
- [Kindeva Drug Delivery](/companies/kindevadd)
  - Purpose-driven CDMO specializing in injectable, inhalation, and dermal drug delivery with 155,000+ sq. ft. of aseptic operations and fill-finish capabilities.
- [Medpharm](/companies/medpharm)
  - Specialized CDMO for topical, transdermal, and transepithelial drug products offering formulation development, analytical testing, process scale-up, and GMP manufacturing from early development through commercialization.
- [Pharmaron](/companies/pharmaron)
  - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
- [Siegfried Holding](/companies/siegfried)
  - Global CDMO with 16 production sites across four continents, offering integrated development and manufacturing from early-phase to commercial scale for drug substance and drug product.
- [Unither Pharmaceuticals](/companies/unither-pharma)
  - Global CDMO specializing in sterile and non-sterile liquid manufacturing, including Blow-Fill-Seal (BFS) single-dose technology with over 5 billion annual capacity, plus formulation development, analytical services, and ophthalmic expertise across six production sites.